Meanwhile, apoptosis analysis reflected that CLEC1B overexpressed SMMC-7721 cells were more sensitive to sorafenib (Fig. 8G), indicating that CLEC1B may be a potential target that can affect the cytotoxicity of sorafenib to HCC cells. Here, CLEC1B is linked to hepatocellular carcinoma.